Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | SRC | P12931 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.43 |
| ▸ | TFEB | P19484 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.40 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | TLR4 | O00206 | 1/20 | 0.39 |
| ▸ | TLR2 | O60603 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3669785 | 0.88 | NFE2L2 (0.45) | HTTKMT2AMEN1NFE2L2TFEB | |
| SCHEMBL21110871 | 0.88 | NFE2L2 (0.45) | HTTKMT2AMEN1NFE2L2TFEB | |
| Sulfuric Acid SCHEMBL21110870 | 0.85 | HTT (0.45) | HTTKMT2AMEN1NFE2L2TFEB | |
| SCHEMBL13158806 | 0.84 | SRC (0.66) | SRCKMT2AMEN1NFE2L2TFEB | |
| Sulfuric Acid SCHEMBL3667450 | 0.84 | HTT (0.44) | HTTKMT2AMEN1NFE2L2TFEB | |
| SCHEMBL3672332 | 0.84 | HTT (0.44) | HTTKMT2AMEN1NFE2L2TFEB | |
| SCHEMBL16116225 | 0.81 | HTT (0.45) | HTTKMT2AMEN1NFE2L2TFEB | |
| Phosphoric Acid SCHEMBL22721325 | 0.80 | NFE2L2 (0.58) | HTTSRCKMT2ANFE2L2GAA | |
| SCHEMBL7210051 | 0.79 | SRC (0.46) | HTTSRCKMT2AMEN1NFE2L2 | |
| SCHEMBL7210055 | 0.79 | SRC (0.46) | HTTSRCKMT2AMEN1NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11578028-B2 | Surfactant composition | DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) | 2023-02-14 | — | — | US | claimed |
| WO-2021198866-A1 | BLUE CATHODIC ELECTRODEPOSITION (CED) COATING COMPOSITION | KANSAI NEROLAC PAINTS LIMITED (IN) | 2021-10-07 | — | — | WO | claimed |
| EP-3508269-B1 | SURFACTANT COMPOSITION | DAI ICHI KOGYO SEIYAKU CO LTD (JP) | 2021-06-23 | — | — | EP | claimed |
| US-20200331830-A1 | SURFACTANT COMPOSITION | DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) | 2020-10-22 | — | — | US | claimed |
| US-20190217265-A1 | SURFACTANT COMPOSITION | DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) | 2019-07-18 | — | — | US | claimed |
| CN-115698099-A | Aqueous dispersion, coating agent for metal, and coating film | 第一工业制药株式会社 | 2023-02-03 | — | — | CN | disclosed |
| CN-111253515-B | Aqueous dispersion | 第一工业制药株式会社 | 2022-11-25 | — | — | CN | disclosed |
| CN-111253522-B | Aqueous dispersion | 第一工业制药株式会社 | 2022-10-14 | — | — | CN | disclosed |
| WO-2021198866-A1 | BLUE CATHODIC ELECTRODEPOSITION (CED) COATING COMPOSITION | KANSAI NEROLAC PAINTS LIMITED (IN) | 2021-10-07 | — | — | WO | disclosed |
| CN-111253522-A | Aqueous dispersion | 第一工业制药株式会社 | 2020-06-09 | — | — | CN | disclosed |
| CN-111253515-A | Aqueous dispersion | 第一工业制药株式会社 | 2020-06-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11578028-B2 | Surfactant composition | CHRM1, DEGS1, ASH2L | HTT 2646/4885SRC 3879/4885KMT2A 866/4885 |
| US-20200331830-A1 | SURFACTANT COMPOSITION | CHRM1, DEGS1, ASH2L | HTT 2646/4885SRC 3879/4885KMT2A 866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.